S-1/A//SEC Filing
ANTHRA PHARMACEUTICALS INC S-1/A
Accession 0000950123-98-005359
CIK 0001054839other
Filed
May 20, 8:00 PM ET
Accepted
—
Size
991.9 KB
Accession
0000950123-98-005359
Documents
- S-1
AMENDMENT NO. 3 TO FORM S-1
- EX-1
FORM OF UNDERWRITING AGREEMENT
- EX-4.2
SPECIMEN COMMON STOCK CERTIFICATE
- EX-10.1
AGREEMENT WITH DANA-FARBER CANCER INSTITUTE
- EX-10.4
EXCLUSIVE SUPPLY AGREEMENT
- EX-10.5
TERMINATION, SETTLEMENT AND INVESTMENT AGREEMENT
- EX-10.9
EXCLUSIVE LICENSE AGREEMENT
- EX-10.11
DEVELOPMENT AGREEMENT
- EX-10.12
SUPPLY AGREEMENT
- EX-10.14
LICENSE, SALE AND DISTRIBUTION AGREEMENT
- EX-10.15
TERM SHEET
- EX-23.1
CONSENT OF KPMG PEAT MARWICK LLP.
- EX-23.2
CONSENT OF MEDPROBE, INC.
Issuer
ANTHRA PHARMACEUTICALS INC
CIK 0001054839
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001054839
Filing Metadata
- Form type
- S-1/A
- Filed
- May 20, 8:00 PM ET
- Size
- 991.9 KB